Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Laroni

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Neurology|November 3, 2023
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster doseMassimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori, et al.
Journal of Neurology|March 18, 2018
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT studyRoberta Lanzillo, Luca Prosperini, Claudio Gasperini, et al.
Journal of the Neurological Sciences|March 26, 2021
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian studyStefania Federica De Mercanti, Alessio Signori, Cinzia Cordioli, et al.
Cell Reports|November 13, 2025
Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosisTiziana Vigo, Maria C Mariani, Caterina Bason, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisMassimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
European Journal of Neurology|September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patientsCinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Neurology|November 3, 2023
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster doseMassimiliano Di Filippo, Diana Ferraro, Paolo Ragonese, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori, et al.
Journal of Neurology|March 18, 2018
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT studyRoberta Lanzillo, Luca Prosperini, Claudio Gasperini, et al.
Journal of the Neurological Sciences|March 26, 2021
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian studyStefania Federica De Mercanti, Alessio Signori, Cinzia Cordioli, et al.
Cell Reports|November 13, 2025
Noradrenergic control of bone marrow and thymus by AgRP neurons is impaired in experimental multiple sclerosisTiziana Vigo, Maria C Mariani, Caterina Bason, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapiesIrene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian studyMarta Ponzano, Alessio Signori, Irene Schiavetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisMassimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
European Journal of Neurology|September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patientsCinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
Pageof 8